Morgan Stanley Cryo Cell International Inc Transaction History

Morgan Stanley

$1.49 Trillion
Q2 2025

A detailed history of Morgan Stanley transactions in Cryo Cell International Inc stock. As of the latest transaction made, Morgan Stanley holds 601 shares of CCEL stock, worth $2,830. This represents 0.0% of its overall portfolio holdings.

Number of Shares

601

Previous 601 -0.0%

Holding current value

$2,830

Previous $3,000 -0.0%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$5.82 - $9.27 $5 - $9	1 Added 0.17%	601 $4,000
Q3 2024 May 14, 2025	SELL	$6.17 - $7.92 $6 - $7	-1 Reduced 0.17%	600 $3,000
Q3 2024 Nov 14, 2024	SELL	$6.17 - $7.92 $6 - $7	-1 Reduced 0.17%	600 $3,000
Q2 2024 Oct 17, 2024	BUY	$6.7 - $9.38 $6 - $9	1 Added 0.17%	601 $4,000
Q2 2024 Aug 14, 2024	BUY	$6.7 - $9.38 $6 - $9	1 Added 0.17%	601 $4,000
Q1 2024 Oct 17, 2024	SELL	$4.86 - $8.04 $4 - $8	-1 Reduced 0.17%	600 $4,000
Q4 2023 Aug 16, 2024	SELL	$4.19 - $6.6 $4 - $6	-1 Reduced 0.17%	600 $3,000
Q4 2023 Feb 13, 2024	BUY	$4.19 - $6.6 $838 - $1,320	200 Added 50.0%	600 $3,000
Q1 2023 May 15, 2023	SELL	$2.97 - $4.66 $1,188 - $1,864	-400 Reduced 50.0%	400 $1,000
Q2 2022 Oct 27, 2022	BUY	$5.83 - $7.71 $2,332 - $3,084	400 Added 100.0%	800 $5,000
Q2 2022 Aug 15, 2022	BUY	$5.83 - $7.71 $2,332 - $3,084	400 Added 100.0%	800 $5,000
Q1 2022 Oct 27, 2022	SELL	$7.28 - $11.84 $2,912 - $4,736	-400 Reduced 50.0%	400 $3,000
Q4 2021 Feb 14, 2022	SELL	$11.27 - $13.9 $3,381 - $4,170	-300 Reduced 42.86%	400 $5,000
Q3 2021 Nov 15, 2021	BUY	$8.97 - $14.16 $6,279 - $9,912	700 New	700 $8,000

Others Institutions Holding CCEL

# of Institutions

Shares Held

975K

Call Options Held

Put Options Held

View Full List

About CRYO CELL INTERNATIONAL INC

Ticker CCEL
Exchange NASDAQ
Sector Healthcare
Industry Medical Care Facilities
Shares Outstandng 8,519,250
Market Cap $40.1M
Description
Cryo-Cell International, Inc. engages in the cellular processing and cryogenic cellular storage with a focus on the collection and preservation of umbilical cord blood stem cells for family use. It provides cord tissue service that stores a section of the umbilical cord tissue, a source of mesenchymal stem cells that are used in regenerative med...

More about CCEL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account